| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/10799890903047437 |
| P698 | PubMed publication ID | 19586284 |
| P2093 | author name string | Evi Kostenis | |
| Klaus Mohr | |||
| Anna Kebig | |||
| Marion Mohr-Andrä | |||
| P2860 | cites work | Allosteric modulation of muscarinic receptor signaling: alcuronium-induced conversion of pilocarpine from an agonist into an antagonist | Q28215186 |
| Beta-arrestin-biased ligands at seven-transmembrane receptors | Q34654662 | ||
| Allosterism at muscarinic receptors: ligands and mechanisms | Q36172717 | ||
| Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors | Q36880900 | ||
| Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development | Q36925551 | ||
| Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity | Q39931162 | ||
| Estimation of agonist activity at G protein-coupled receptors: analysis of M2 muscarinic receptor signaling through Gi/o,Gs, and G15. | Q40152913 | ||
| Non-invasive optical biosensor for assaying endogenous G protein-coupled receptors in adherent cells. | Q40185924 | ||
| Resonant waveguide grating biosensor for living cell sensing. | Q40269125 | ||
| Allosteric regulation of cloned m1–m5 muscarinic receptor subtypes | Q41660421 | ||
| An investigation of whether agonist-selective receptor conformations occur with respect to M2 and M4 muscarinic acetylcholine receptor signalling via Gi/o and Gs proteins | Q41869522 | ||
| Non-invasive Optical Biosensor for Probing Cell Signaling. | Q42122607 | ||
| Evaluation of dynamic mass redistribution technology for pharmacological studies of recombinant and endogenously expressed g protein-coupled receptors | Q43646655 | ||
| Allosteric site on muscarinic acetylcholine receptors: a single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands | Q43830232 | ||
| Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-o | Q44483391 | ||
| Functional selectivity of GPCR ligand stereoisomers: new pharmacological opportunities | Q46253304 | ||
| Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors | Q46879304 | ||
| Synthesis and functional characterization of novel derivatives related to oxotremorine and oxotremorine-M. | Q46907066 | ||
| Allosteric small molecules unveil a role of an extracellular E2/transmembrane helix 7 junction for G protein-coupled receptor activation | Q46985701 | ||
| Muscarinic M2 receptors directly activate Gq/11 and Gs G-proteins. | Q51802778 | ||
| P433 | issue | 3-4 | |
| P921 | main subject | G protein-coupled receptor | Q38173 |
| bias | Q742736 | ||
| P304 | page(s) | 140-145 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Journal of Receptors and Signal Transduction | Q6295837 |
| P1476 | title | An optical dynamic mass redistribution assay reveals biased signaling of dualsteric GPCR activators | |
| P478 | volume | 29 |
| Q37532303 | Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities |
| Q37416470 | Allosteric modulators of g protein-coupled receptors: future therapeutics for complex physiological disorders. |
| Q38209355 | Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective. |
| Q55513558 | Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes. |
| Q50323703 | Cocaine Effects on Dopaminergic Transmission Depend on a Balance between Sigma-1 and Sigma-2 Receptor Expression. |
| Q58687097 | Label-Free Biosensors for Cell Biology |
| Q28477403 | Ligand-directed functional selectivity at the mu opioid receptor revealed by label-free integrative pharmacology on-target |
| Q38031893 | Ligand-receptor interaction platforms and their applications for drug discovery. |
| Q58856223 | M1 muscarinic cetylcholine receptor allosteric modulators as potential therapeutic opportunities for treating Alzheimer's disease |
| Q38218059 | Muscarinic acetylcholine receptors: novel opportunities for drug development |
| Q34343837 | PROBING CANCER SIGNALING WITH RESONANT WAVEGUIDE GRATING BIOSENSORS |
| Q39288199 | Pro-fibrotic processes in human lung fibroblasts are driven by an autocrine/paracrine endothelinergic system |
| Q37688232 | Rational design of dualsteric GPCR ligands: quests and promise |
| Q34438026 | Resonant waveguide grating imager for live cell sensing. |
| Q47685791 | The development of label-free cellular assays for drug discovery |
| Q39538307 | The β2-subtype of adrenoceptors mediates inhibition of pro-fibrotic events in human lung fibroblasts |
Search more.